source
- Charles River partners with Ipsen to employ virtual control groups in toxicology studiesCharles River Laboratories and French biopharma Ipsen announced a collaboration to use Charles River’s virtual control group (VCG) database in an upcoming toxicology study. The VCG approach aims t…
- AbbVie licenses Nxera's EP4 gut-targeting IBD program for up to $1.47 billionAbbVie announced a licensing agreement with Nxera Pharma to acquire rights to its EP4 receptor agonist program aimed at inflammatory bowel disease. The deal includes an upfront payment of $100 mil…